BOTHELL, Wash. (AP) _ Alder BioPharmaceuticals Inc. (ALDR) on Thursday reported a loss of $117.9 million in its first quarter.
The Bothell, Washington-based company said it had a loss of $1.63 per share.
The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.16 per share.
Alder BioPharmaceuticals shares have climbed 19% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $12.24, a decline of 12% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALDR at https://www.zacks.com/ap/ALDR